Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Belite Bio Inc ADR (BLTE)

Belite Bio Inc ADR (BLTE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Belite Bio Inc ADR 12750 HIGH BLUFF DRIVE SUITE 475 SAN DIEGO CA 92130 USA

https://belitebio.com Employees: 20 P: 858-246-6240

Description:

Belite Bio Inc. is a clinical stage biopharmaceutical drug development company focused on novel therapeutics targeting currently untreatable eye diseases involving retinal degeneration, such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease, and metabolic diseases. Belite Bio Inc. is based in SAN DIEGO.

Key Statistics

Overview:

Market Capitalization, $K 2,526,408
Enterprise Value, $K 2,438,248
Shares Outstanding, K 30,612
Annual Sales, $ 0 K
Annual Net Income, $ -31,630 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -8,680 K
EBIT, $ -35,500 K
EBITDA, $ -35,100 K
60-Month Beta -1.60
% of Insider Shareholders 13.29%
% of Institutional Shareholders 0.53%
Float, K 26,544
% Float 86.71%
Short Volume Ratio 0.63

Growth:

1-Year Return 107.43%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.28 on 11/12/24
Next Earnings Date N/A
Earnings Per Share ttm -1.11
EPS Growth vs. Prev Qtr 9.68%
EPS Growth vs. Prev Year 30.00%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

BLTE Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -31.94%
Return-on-Assets % -30.73%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 22.58
Book Value/Share 3.67
Interest Coverage -1,053.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar